183 related articles for article (PubMed ID: 18467665)
1. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes.
Metsuyanim S; Pode-Shakked N; Schmidt-Ott KM; Keshet G; Rechavi G; Blumental D; Dekel B
Stem Cells; 2008 Jul; 26(7):1808-17. PubMed ID: 18467665
[TBL] [Abstract][Full Text] [Related]
2. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney.
Dekel B; Metsuyanim S; Schmidt-Ott KM; Fridman E; Jacob-Hirsch J; Simon A; Pinthus J; Mor Y; Barasch J; Amariglio N; Reisner Y; Kaminski N; Rechavi G
Cancer Res; 2006 Jun; 66(12):6040-9. PubMed ID: 16778176
[TBL] [Abstract][Full Text] [Related]
3. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
Rajasekhar VK; Begemann M
Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
[TBL] [Abstract][Full Text] [Related]
4. C-myc as a modulator of renal stem/progenitor cell population.
Couillard M; Trudel M
Dev Dyn; 2009 Feb; 238(2):405-14. PubMed ID: 19161241
[TBL] [Abstract][Full Text] [Related]
5. The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.
Senanayake U; Koller K; Pichler M; Leuschner I; Strohmaier H; Hadler U; Das S; Hoefler G; Guertl B
Hum Pathol; 2013 Mar; 44(3):336-45. PubMed ID: 22995329
[TBL] [Abstract][Full Text] [Related]
6. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.
Yu J; Yu J; Rhodes DR; Tomlins SA; Cao X; Chen G; Mehra R; Wang X; Ghosh D; Shah RB; Varambally S; Pienta KJ; Chinnaiyan AM
Cancer Res; 2007 Nov; 67(22):10657-63. PubMed ID: 18006806
[TBL] [Abstract][Full Text] [Related]
7. The murine Pou6f2 gene is temporally and spatially regulated during kidney embryogenesis and its human homolog is overexpressed in a subset of Wilms tumors.
Di Renzo F; Doneda L; Menegola E; Sardella M; De Vecchi G; Collini P; Spreafico F; Fossati-Bellani F; Giavini E; Radice P; Perotti D
J Pediatr Hematol Oncol; 2006 Dec; 28(12):791-7. PubMed ID: 17164647
[TBL] [Abstract][Full Text] [Related]
8. The Wilms' tumor gene WT1 is a common marker of progenitor cells in fetal liver.
Kanato K; Hosen N; Yanagihara M; Nakagata N; Shirakata T; Nakazawa T; Nishida S; Tsuboi A; Kawakami M; Masuda T; Oka Y; Oji Y; Ijpenberg A; Hastie ND; Sugiyama H
Biochem Biophys Res Commun; 2005 Jan; 326(4):836-43. PubMed ID: 15607745
[TBL] [Abstract][Full Text] [Related]
9. Identification of kidney mesenchymal genes by a combination of microarray analysis and Sall1-GFP knockin mice.
Takasato M; Osafune K; Matsumoto Y; Kataoka Y; Yoshida N; Meguro H; Aburatani H; Asashima M; Nishinakamura R
Mech Dev; 2004 Jun; 121(6):547-57. PubMed ID: 15172686
[TBL] [Abstract][Full Text] [Related]
10. WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts.
Hosono S; Luo X; Hyink DP; Schnapp LM; Wilson PD; Burrow CR; Reddy JC; Atweh GF; Licht JD
Oncogene; 1999 Jan; 18(2):417-27. PubMed ID: 9927198
[TBL] [Abstract][Full Text] [Related]
11. Identifying the molecular phenotype of renal progenitor cells.
Challen GA; Martinez G; Davis MJ; Taylor DF; Crowe M; Teasdale RD; Grimmond SM; Little MH
J Am Soc Nephrol; 2004 Sep; 15(9):2344-57. PubMed ID: 15339983
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of Hox gene activation: the waltz of methyls.
Soshnikova N; Duboule D
Bioessays; 2008 Mar; 30(3):199-202. PubMed ID: 18293357
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic alterations in myelodysplastic syndrome.
Mihara K; Takihara Y; Kimura A
Cytogenet Genome Res; 2007; 118(2-4):297-303. PubMed ID: 18000383
[TBL] [Abstract][Full Text] [Related]
14. WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2.
Discenza MT; He S; Lee TH; Chu LL; Bolon B; Goodyer P; Eccles M; Pelletier J
Oncogene; 2003 Nov; 22(50):8145-55. PubMed ID: 14603255
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
16. Polycomb gene expression and histone H3 lysine 27 trimethylation changes during bovine preimplantation development.
Ross PJ; Ragina NP; Rodriguez RM; Iager AE; Siripattarapravat K; Lopez-Corrales N; Cibelli JB
Reproduction; 2008 Dec; 136(6):777-85. PubMed ID: 18784248
[TBL] [Abstract][Full Text] [Related]
17. [Epigenetic analyses of brain tumor stem cells].
Natsume A; Kondo Y; Wakabayashi T
Brain Nerve; 2009 Jul; 61(7):791-8. PubMed ID: 19618856
[TBL] [Abstract][Full Text] [Related]
18. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
Brown KW; Power F; Moore B; Charles AK; Malik KT
Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia.
Grubach L; Juhl-Christensen C; Rethmeier A; Olesen LH; Aggerholm A; Hokland P; Ostergaard M
Eur J Haematol; 2008 Aug; 81(2):112-22. PubMed ID: 18410541
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
